Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
Oct 02 2026 This Week in Cardiology
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
Listener feedback on DANISH-CRT, the POET II trial, a mechanistic study in obesity and AF, the DANCODE trial of slowing CAC progression, and more on GLP-1 drugs are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Listener Feedback
- DANISH-CRT Trial 10.1016/S0140-6736(26)01597-7
- Identifying LV Posterior Wall Delay in RBBB Using Lead V8 https://doi.org/10.1016/j.jacep.2026.03.009
- Using Lead V8 as a Tool to Improve Patient Selection in CRT https://doi.org/10.1093/europace/euaf194
II POET II Response-Tailored or Standard-Duration Antibiotics for Endocarditis
- POET I https://www.nejm.org/doi/10.1056/NEJMoa1808312
- POET II https://www.nejm.org/doi/full/10.1056/NEJMoa2607887
III Obesity and AF – A Neat Study from the Team in Prague
- LA Remodeling and Functional Maladaptations in Obesity https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.126.014509
IV Reducing CAC: The DANCODE Trial
- DANCODE Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.082363
V Two Big RCTs of New GLP-1 Drugs
- TRIUMPH-1 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2604169
- SYNCHRONIZE-2 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607219
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net